The store will not work correctly when cookies are disabled.
5-((5H-dibenzo[b,f]azepin-5-yl)methyl)-3-(4-nitrophenyl)isoxazole
ID: ALA4852983
Chembl Id: CHEMBL4852983
PubChem CID: 164615064
Max Phase: Preclinical
Molecular Formula: C24H17N3O3
Molecular Weight: 395.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=[N+]([O-])c1ccc(-c2cc(CN3c4ccccc4C=Cc4ccccc43)on2)cc1
Standard InChI: InChI=1S/C24H17N3O3/c28-27(29)20-13-11-17(12-14-20)22-15-21(30-25-22)16-26-23-7-3-1-5-18(23)9-10-19-6-2-4-8-24(19)26/h1-15H,16H2
Standard InChI Key: JELSKIYJCLMNKG-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 395.42 | Molecular Weight (Monoisotopic): 395.1270 | AlogP: 6.07 | #Rotatable Bonds: 4 |
Polar Surface Area: 72.41 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.99 | CX LogD: 5.99 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.31 | Np Likeness Score: -1.19 |
References
1. Umm-E-Farwa, Ullah S, Khan MA, Zafar H, Atia-Tul-Wahab, Younus M, Choudhary MI, Basha FZ.. (2021) Dibenzazepine-linked isoxazoles: New and potent class of α-glucosidase inhibitors., 40 [PMID:33766763] [10.1016/j.bmcl.2021.127979] |